Posted On: 01/07/2014 11:49:12 AM
Post# of 144842
$BMY Company News
Not all pharmaceuticals are created equal 12:40 p.m. Dec. 26, 2013 - The Trading Deck
FTSE 100 rises, shaking off retail data after Fed taper 12:06 p.m. Dec. 19, 2013 - Sara Sjolin
European stocks rally on Fed taper, rate views 12:00 p.m. Dec. 19, 2013 - Sara Sjolin
AstraZeneca to buy Bristol-Myers diabetes-JV stake 3:25 a.m. Dec. 19, 2013 - MarketWatch.com
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - Russ Britt
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
S&P, Dow hold tightly to record territory 10:36 a.m. Nov. 4, 2013 - Michael Ashbaugh
J.C. Penney, Bristol-Myers top S&P 500 6:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 3:58 p.m. Oct. 28, 2013 - Victor Reklaitis
Bristol-Myers shares jump on promising results for two new drugs 10:58 a.m. Oct. 28, 2013 - Russ Britt
Bristol-Myers Squibb leads S&P 500 gainers, up 5% 8:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 8:31 a.m. Oct. 28, 2013 - Victor Reklaitis
Bristol-Myers lifted to overweight: Morgan Stanley 7:16 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Drug-maker earnings come in ahead of views, but stocks aren't rewarded 10:45 a.m. Oct. 23, 2013 - Russ Britt
Stock futures retreat; Cat misses on earnings 7:42 a.m. Oct. 23, 2013 - William L. Watts
Bristol-Myers swings to profit; sales grow again 6:43 a.m. Oct. 23, 2013 - MarketWatch.com
Boeing, AT&T, Caterpillar are stocks to watch 4:31 a.m. Oct. 23, 2013 - Sue Chang
No shortcut to innovation 7:30 a.m. Oct. 2, 2013 - Mark Hulbert
A strong 2014 will take the S&P over 2,000 10:41 a.m. Sept. 24, 2013 - The Trading Deck
Is the Biotech Boom Over? 50 min ago - Barrons.com
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Today - TheStreet.com
Exelixis Has A Stellar Year Ahead 5:21 p.m. Jan. 6, 2014 - Seeking Alpha
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner 5:00 p.m. Jan. 3, 2014 - TheStreet.com
5 Stocks Improving Performance Of The Drugs Industry 12:03 p.m. Jan. 3, 2014 - TheStreet.com
Valeant Is Having a Healthy Run 6:30 a.m. Jan. 3, 2014 - TheStreet.com
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race 8:58 a.m. Jan. 2, 2014 - Seeking Alpha
Dividend Champions For January 2014 12:17 a.m. Jan. 2, 2014 - Seeking Alpha
The Top Five Drug Launches Of 2013 12:42 p.m. Dec. 31, 2013 - Investors Business Daily
Jazz, Valeant Join Drug Makers' Q4 Merger Rush 5:39 p.m. Dec. 30, 2013 - Investors Business Daily
Bristol-Myers' AstraZeneca Deal Is a Win 3:18 p.m. Dec. 30, 2013 - Barrons.com
Tuesday's Ex-Dividends To Watch: RCII, TMK, SYY, BMY 10:00 a.m. Dec. 30, 2013 - TheStreet.com
Getting The New Year Off To A Bad Start 11:10 a.m. Dec. 28, 2013 - Seeking Alpha
New Drugs Could Change Cancer Landscape In 2014 5:20 p.m. Dec. 27, 2013 - Investors Business Daily
3 Stocks Dragging In The Drugs Industry 12:03 p.m. Dec. 27, 2013 - TheStreet.com
5 Pharmaceutical Stocks to Buy Now 6:30 a.m. Dec. 27, 2013 - InvestorPlace.com
Cramer's 'Mad Money' Recap: Timing Is Everything 6:00 p.m. Dec. 26, 2013 - TheStreet.com
Genetic Technologies updates patent program, grants license 8:19 a.m. Dec. 24, 2013 - Seeking Alpha
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
Gilead Sciences And The Numbers Game 9:51 a.m. Dec. 23, 2013 - Seeking Alpha
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Today - PR Newswire
Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2013 on January 24 3:15 p.m. Jan. 6, 2014 - BusinessWire
Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference 11:02 a.m. Jan. 6, 2014 - BusinessWire
Bristol-Myers Squibb to Take Part in Goldman Sachs Healthcare CEOs Unscripted Conference 2:29 p.m. Jan. 3, 2014 - BusinessWire
New Business Ventures, Quarterly Dividends, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, DENTSPLY, Pharmacyclics, and St. Jude Medical 8:00 a.m. Dec. 25, 2013 - PR Newswire
Fitch Revises Bristol-Myers Squibb's Rating Outlook to Negative; Affirms IDR at 'A-' 1:49 p.m. Dec. 23, 2013 - BusinessWire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Heineken N.V. to nominate Mr. Jean-Marc Huet as Supervisory Board member 2:01 a.m. Dec. 20, 2013 - Thomson Reuters ONE
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire
Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022 1:00 p.m. Dec. 19, 2013 - PR Newswire
The Novel Oral Anticoagulants Will Continue to Drive Growth in the Atrial Fibrillation Drug Market 11:00 a.m. Dec. 19, 2013 - PR Newswire
Bristol-Myers Squibb Announces Dividend Increase 3:34 a.m. Dec. 19, 2013 - BusinessWire
Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business 2:56 a.m. Dec. 19, 2013 - BusinessWire
Critical Alerts For 21st Century Fox, Whole Foods Market, Rackspace, Vodafone, and Bristol-Myers Squibb Released By InvestorsObserver 9:31 a.m. Dec. 18, 2013 - PR Newswire
Bristol-Myers Squibb Foundation Awards $3.28 Million in Grants to Support Mental Health Needs of U.S. Military Service Members Returning from Afghanistan and Iraq 9:00 a.m. Dec. 17, 2013 - BusinessWire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
FDA Advisory Committee Recommends the Investigational SGLT2 Inhibitor Dapagliflozin for the Treatment of Type 2 Diabetes in Adults 6:59 p.m. Dec. 12, 2013 - BusinessWire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee Votes on Investigational Medicine Metreleptin 9:49 p.m. Dec. 11, 2013 - BusinessWire
Not all pharmaceuticals are created equal 12:40 p.m. Dec. 26, 2013 - The Trading Deck
FTSE 100 rises, shaking off retail data after Fed taper 12:06 p.m. Dec. 19, 2013 - Sara Sjolin
European stocks rally on Fed taper, rate views 12:00 p.m. Dec. 19, 2013 - Sara Sjolin
AstraZeneca to buy Bristol-Myers diabetes-JV stake 3:25 a.m. Dec. 19, 2013 - MarketWatch.com
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - Russ Britt
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
S&P, Dow hold tightly to record territory 10:36 a.m. Nov. 4, 2013 - Michael Ashbaugh
J.C. Penney, Bristol-Myers top S&P 500 6:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 3:58 p.m. Oct. 28, 2013 - Victor Reklaitis
Bristol-Myers shares jump on promising results for two new drugs 10:58 a.m. Oct. 28, 2013 - Russ Britt
Bristol-Myers Squibb leads S&P 500 gainers, up 5% 8:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 8:31 a.m. Oct. 28, 2013 - Victor Reklaitis
Bristol-Myers lifted to overweight: Morgan Stanley 7:16 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Drug-maker earnings come in ahead of views, but stocks aren't rewarded 10:45 a.m. Oct. 23, 2013 - Russ Britt
Stock futures retreat; Cat misses on earnings 7:42 a.m. Oct. 23, 2013 - William L. Watts
Bristol-Myers swings to profit; sales grow again 6:43 a.m. Oct. 23, 2013 - MarketWatch.com
Boeing, AT&T, Caterpillar are stocks to watch 4:31 a.m. Oct. 23, 2013 - Sue Chang
No shortcut to innovation 7:30 a.m. Oct. 2, 2013 - Mark Hulbert
A strong 2014 will take the S&P over 2,000 10:41 a.m. Sept. 24, 2013 - The Trading Deck
Is the Biotech Boom Over? 50 min ago - Barrons.com
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Today - TheStreet.com
Exelixis Has A Stellar Year Ahead 5:21 p.m. Jan. 6, 2014 - Seeking Alpha
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner 5:00 p.m. Jan. 3, 2014 - TheStreet.com
5 Stocks Improving Performance Of The Drugs Industry 12:03 p.m. Jan. 3, 2014 - TheStreet.com
Valeant Is Having a Healthy Run 6:30 a.m. Jan. 3, 2014 - TheStreet.com
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race 8:58 a.m. Jan. 2, 2014 - Seeking Alpha
Dividend Champions For January 2014 12:17 a.m. Jan. 2, 2014 - Seeking Alpha
The Top Five Drug Launches Of 2013 12:42 p.m. Dec. 31, 2013 - Investors Business Daily
Jazz, Valeant Join Drug Makers' Q4 Merger Rush 5:39 p.m. Dec. 30, 2013 - Investors Business Daily
Bristol-Myers' AstraZeneca Deal Is a Win 3:18 p.m. Dec. 30, 2013 - Barrons.com
Tuesday's Ex-Dividends To Watch: RCII, TMK, SYY, BMY 10:00 a.m. Dec. 30, 2013 - TheStreet.com
Getting The New Year Off To A Bad Start 11:10 a.m. Dec. 28, 2013 - Seeking Alpha
New Drugs Could Change Cancer Landscape In 2014 5:20 p.m. Dec. 27, 2013 - Investors Business Daily
3 Stocks Dragging In The Drugs Industry 12:03 p.m. Dec. 27, 2013 - TheStreet.com
5 Pharmaceutical Stocks to Buy Now 6:30 a.m. Dec. 27, 2013 - InvestorPlace.com
Cramer's 'Mad Money' Recap: Timing Is Everything 6:00 p.m. Dec. 26, 2013 - TheStreet.com
Genetic Technologies updates patent program, grants license 8:19 a.m. Dec. 24, 2013 - Seeking Alpha
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
Gilead Sciences And The Numbers Game 9:51 a.m. Dec. 23, 2013 - Seeking Alpha
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Today - PR Newswire
Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2013 on January 24 3:15 p.m. Jan. 6, 2014 - BusinessWire
Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference 11:02 a.m. Jan. 6, 2014 - BusinessWire
Bristol-Myers Squibb to Take Part in Goldman Sachs Healthcare CEOs Unscripted Conference 2:29 p.m. Jan. 3, 2014 - BusinessWire
New Business Ventures, Quarterly Dividends, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, DENTSPLY, Pharmacyclics, and St. Jude Medical 8:00 a.m. Dec. 25, 2013 - PR Newswire
Fitch Revises Bristol-Myers Squibb's Rating Outlook to Negative; Affirms IDR at 'A-' 1:49 p.m. Dec. 23, 2013 - BusinessWire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Heineken N.V. to nominate Mr. Jean-Marc Huet as Supervisory Board member 2:01 a.m. Dec. 20, 2013 - Thomson Reuters ONE
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire
Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022 1:00 p.m. Dec. 19, 2013 - PR Newswire
The Novel Oral Anticoagulants Will Continue to Drive Growth in the Atrial Fibrillation Drug Market 11:00 a.m. Dec. 19, 2013 - PR Newswire
Bristol-Myers Squibb Announces Dividend Increase 3:34 a.m. Dec. 19, 2013 - BusinessWire
Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business 2:56 a.m. Dec. 19, 2013 - BusinessWire
Critical Alerts For 21st Century Fox, Whole Foods Market, Rackspace, Vodafone, and Bristol-Myers Squibb Released By InvestorsObserver 9:31 a.m. Dec. 18, 2013 - PR Newswire
Bristol-Myers Squibb Foundation Awards $3.28 Million in Grants to Support Mental Health Needs of U.S. Military Service Members Returning from Afghanistan and Iraq 9:00 a.m. Dec. 17, 2013 - BusinessWire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
FDA Advisory Committee Recommends the Investigational SGLT2 Inhibitor Dapagliflozin for the Treatment of Type 2 Diabetes in Adults 6:59 p.m. Dec. 12, 2013 - BusinessWire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee Votes on Investigational Medicine Metreleptin 9:49 p.m. Dec. 11, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼
